SDT Treatment (Sonodynamic Therapy)
Sonodynamic Therapy (SDT) uses low-intensity ultrasound to activate a sensitizing agent; the SDT mechanism presented in our overview describes ultrasound-triggered activation that can generate reactive oxygen species in tumor tissue and contribute to targeted cell damage.
The SDT overview also describes ultrasound cavitation concepts and energy release at the microscopic level.
Additionally, SDT is presented as a potential “whole body” concept with proposed targeting that may include primary and metastatic tumors as well as circulating/disseminated tumor cells.







